Casey Means, Trump’s Pick for Surgeon General, Walks Fine Line on Vaccines in Senate Hearing 25/02/2026 Sophia Samantaroy Surgeon General nominee Dr Casey Means, a confidante of HHS Secretary Robert F Kennedy, was grilled in a tense Senate confirmation hearing on Wednesday. She fielded questions on vaccines, her conflicts of interest, pesticides, and birth control, and reaffirmed her focus on America’s chronic disease epidemic, promising to use her platform to promote “whole healthy […] Continue reading -> More US Vaccine Contestation Ahead Amid Court Action and Senate Hearing for Trump’s Surgeon General Nominee 23/02/2026 Kerry Cullinan The US Health and Human Services (HHS) has cancelled this week’s meeting of its Advisory Committee on Immunization Practices (ACIP) amid a court challenge to the committee’s composition and decisions, led by the American Academy of Pediatrics (AAP). Meanwhile, the long-delayed Senate panel confirmation hearing for US President Donald Trump’s nominee for Surgeon General, Casey […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> A Flag Recaptured: US Exit from WHO Highlights Anger Over COVID-19 Pandemic 27/01/2026 Sophia Samantaroy A dispute over an American flag has become symbolic of the bitter public dispute between the US and the World Health Organization (WHO) after the US withdrew from the organization on 22 January. In a joint statement by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F Kennedy Jr on […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
More US Vaccine Contestation Ahead Amid Court Action and Senate Hearing for Trump’s Surgeon General Nominee 23/02/2026 Kerry Cullinan The US Health and Human Services (HHS) has cancelled this week’s meeting of its Advisory Committee on Immunization Practices (ACIP) amid a court challenge to the committee’s composition and decisions, led by the American Academy of Pediatrics (AAP). Meanwhile, the long-delayed Senate panel confirmation hearing for US President Donald Trump’s nominee for Surgeon General, Casey […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> A Flag Recaptured: US Exit from WHO Highlights Anger Over COVID-19 Pandemic 27/01/2026 Sophia Samantaroy A dispute over an American flag has become symbolic of the bitter public dispute between the US and the World Health Organization (WHO) after the US withdrew from the organization on 22 January. In a joint statement by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F Kennedy Jr on […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> A Flag Recaptured: US Exit from WHO Highlights Anger Over COVID-19 Pandemic 27/01/2026 Sophia Samantaroy A dispute over an American flag has become symbolic of the bitter public dispute between the US and the World Health Organization (WHO) after the US withdrew from the organization on 22 January. In a joint statement by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F Kennedy Jr on […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> A Flag Recaptured: US Exit from WHO Highlights Anger Over COVID-19 Pandemic 27/01/2026 Sophia Samantaroy A dispute over an American flag has become symbolic of the bitter public dispute between the US and the World Health Organization (WHO) after the US withdrew from the organization on 22 January. In a joint statement by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F Kennedy Jr on […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> A Flag Recaptured: US Exit from WHO Highlights Anger Over COVID-19 Pandemic 27/01/2026 Sophia Samantaroy A dispute over an American flag has become symbolic of the bitter public dispute between the US and the World Health Organization (WHO) after the US withdrew from the organization on 22 January. In a joint statement by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F Kennedy Jr on […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
A Flag Recaptured: US Exit from WHO Highlights Anger Over COVID-19 Pandemic 27/01/2026 Sophia Samantaroy A dispute over an American flag has become symbolic of the bitter public dispute between the US and the World Health Organization (WHO) after the US withdrew from the organization on 22 January. In a joint statement by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F Kennedy Jr on […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Confusion Over ‘Cancellation’ of Controversial Hepatitis B Trial in Guinea-Bissau 16/01/2026 Kerry Cullinan A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […] Continue reading -> Posts navigation Older posts